Zydus receives approval from Health Canada for Liothyronine tablets 5 mcg and 25 mcg
    Home » Drug Approval » Zydus receives approval from Health Canada for Liothyronine tablets 5 mcg and 25 mcg
Drug Approval

Zydus receives approval from Health Canada for Liothyronine tablets 5 mcg and 25 mcg

Liothyronine tablets will be manufactured at Zydus' plant in Ahmedabad SEZ

  • By IPP Bureau | October 07, 2025

Zydus Lifesciences Limited has received NOC (Notice of Compliance) from Health Canada for generic Liothyronine tablets 5 mcg and 25 mcg.

Liothyronine tablets, a synthetic form of the thyroid hormone T3 (triiodothyronine), are primarily indicated for treating hypothyroidism.

ZDS - Liothyronine tablets will be manufactured at Zydus' plant in Ahmedabad SEZ. Liothyronine tablets had annual sales of 10.9 mn CAD (Canadian Dollars) in Canada (IQVIA MAT June 2025).

Upcoming E-conference

Other Related stories

Biocon and Carnegie receive FDA tentative approval for Rifaximin tablets
FDA approves Zydus’ Deflazacort oral suspension, 22.75 mg/mL
FDA supports new ANDA prioritization pilot to support US generic drugs
View More

Interviews

India rema
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex comm
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Our focus
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
View More

Appointments

Pharmanovia appoints Stephan Eder as CEO
Pharmanovia appoints Stephan Eder as CEO
IPA welcomes Dr. Sharvil Patel as President and Glenn Saldanha as Vice President
IPA welcomes Dr. Sharvil Patel as President and Glenn Saldanha as Vice President
A. P. Rameswara Rao appointed National President of BDMAI
A. P. Rameswara Rao appointed National President of BDMAI
View More

Startup

DPIIT and Thermo Fisher Scientific launch BioVerse challenge to fast-track India’s biotech future
DPIIT and Thermo Fisher Scientific launch BioVerse challenge to fast-track India’s biotech future
Lilly opens biotech in San Diego
Lilly opens biotech in San Diego
Bayer launches biotech innovation platform in China
Bayer launches biotech innovation platform in China
View More

Digitization

Roche’s AI-based kidney disease algorithm gains European certification
Roche’s AI-based kidney disease algorithm gains European certification
ACL Digital acquires US-based CRO Symbiance to expand clinical research capabilities
ACL Digital acquires US-based CRO Symbiance to expand clinical research capabilities
Revvity launches AI-powered software to transform preclinical imaging analysis
Revvity launches AI-powered software to transform preclinical imaging analysis
View More

Latest Stories

Datroway delivers first-ever overall survival breakthrough in 1st-line metastatic triple-negative breast cancer without immunotherapy

Pharmanovia appoints Stephan Eder as CEO

Alembic and Amlan launch feed additive solutions for poultry

Biocon and Carnegie receive FDA tentative approval for Rifaximin tablets

Briefs: Shilpa Medicare and Medico Remedies

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India
From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India

Interviews
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging
UFlex secures Indian patent for waterborne heat seal coating for food, consumer goods packaging
UFlex secures Indian patent for waterborne heat seal coating for food, consumer goods packaging
Sanner commences manufacturing critical injection-molded components in USA
Sanner commences manufacturing critical injection-molded components in USA
UFlex introduces FSSAI compliant single-pellet solution for food packaging
UFlex introduces FSSAI compliant single-pellet solution for food packaging